Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
glp 1 vs glp 3 GLP-3 RT (LY3437943) — Triple-Action Research Compound Blood Sugar Levels Supply Options:6 Month Supply Comparing Semaglutide, Liraglutide, and
Comparing Semaglutide, Liraglutide, and Tirzepatide: Key Insights
2024;26(Suppl 4):16–27
Blood Sugar Levels
Supply Options:6 Month Supply
Unlike earlier GLP-1 receptor agonists, retatrutide is a triple agonist : GLP-1 receptor agonist – suppresses appetite, slows gastric emptying, improves insulin sensitivity GIP receptor agonist – enhances insulin release, amplifies GLP-1 effects Glucagon receptor agonist – stimulates energy expenditure, fat metabolism, and potentially impacts lipid handling Clinical trials so far have shown remarkable weight loss (up to 24% in some studies) and strong metabolic improvements, including effects on lipids like LDL cholesterol
